In babies, endoscopic retrograde cholangiopancreatography (ERCP) is a highly specialized technique. Since 2014, there have been no chances to maintain or acquire duodenoscopes for ERCP in babies. Researchers assessed the availability, necessity, indications, and practice of ERCP operations in babies in a survey of European hepatology institutions. It demonstrates that baby ERCP is a low-volume operation in the 14 institutions that conduct it. Due to equipment failure, some facilities have been without a baby ERCP duodenoscope since 2014. Furthermore, there are significant disparities across institutions in terms of indications, types of treatments done, and actual execution of ERCP operations in newborns. 

They believe that the pediatric hepatology community must work together to ensure the future availability of baby ERCP. Furthermore, agreement on the indications and optimal usage of infant ERCP might increase the quality of newborn ERCP therapy.